AUG 25, 2020 8:20 AM PDT

Targeting Checkpoint Molecule Could Mean Checkmate for Cancer

WRITTEN BY: Tara Fernandez


In a new study published in Cell, researchers have identified a metabolic enzyme that could have powerful tumor-killing effects when targeted by immunotherapies. Interleukin-4-Induced-1, or IL4I1, is secreted in large quantities by tumors, naturally promoting the spread of cancers while simultaneously suppressing the immune system.

Immunotherapies are drug modality that works by either activating or quietening the immune system, helping the body to fight autoimmune conditions, infectious diseases, and cancer. For oncology applications, a variety of immunotherapies are currently available including T cell transfer therapies, monoclonal antibodies, cancer vaccines, and immune checkpoint inhibitors. While in theory, these approaches hold promise, clinical results have often fallen flat, leading researchers to identify fresh ways of boosting their efficacy on a molecular level.

IL4I1 was of particular interest to oncology researchers as a potential target because of its ability to promote cancer cell motility, dampen the adaptive immune response to cancer, and also its correlation with reduced survival in glioma (a malignant brain cancer) patients. The study’s authors saw similar observations in mouse models of glioma, as noted by study author Martina Seiffert from the German Cancer Research Center (DKFZ).

“In animals that do not produce IL4I1 in the tumor environment due to genetic alterations, the immune system is significantly more successful in preventing the cancer from progressing,” said Seiffert.

Their results put IL4I1 within the crosshairs as a prime target for future immunotherapies. As Christiane Opitz, a research group leader at DKFZ concludes, “IL4I1 has great potential as a target for drugs. So far, drugs that inhibit enzymes of the tryptophan metabolism have failed in clinical trials because the tumors did not respond to them. However, the role of IL4I1 has so far been disregarded, and this enzyme has not yet been tested as a target molecule.”

 

 

Sources: Cell, Genetic Engineering & Biotechnology News.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 11, 2020
Drug Discovery & Development
Scientists Discover Key Gene Behind Antibiotic Resistance
AUG 11, 2020
Scientists Discover Key Gene Behind Antibiotic Resistance
Scientists from Oxford University have shown that a single gene can make some strains of Staphylococcus aureus (the bact ...
AUG 12, 2020
Immunology
Is Gluten Becoming More Immunoreactive?
AUG 12, 2020
Is Gluten Becoming More Immunoreactive?
In recent years, the number of people diagnosed with celiac disease has increased drastically, even with many undiagnose ...
AUG 19, 2020
Cell & Molecular Biology
Mild COVID-19 Cases Induce an Immune Cell Response
AUG 19, 2020
Mild COVID-19 Cases Induce an Immune Cell Response
As the pandemic virus, SARS-CoV-2 continues to cause tens of thousands of new cases of COVID-19 every day in the United ...
SEP 28, 2020
Genetics & Genomics
Why Some Young, Healthy People Get Severe COVID-19
SEP 28, 2020
Why Some Young, Healthy People Get Severe COVID-19
Since the start of the pandemic, scientists have been trying to find out why some people get such severe illness from SA ...
OCT 26, 2020
Immunology
Gearing up for Life: The First 7 Days of the Immune System
OCT 26, 2020
Gearing up for Life: The First 7 Days of the Immune System
The mother’s placenta serves as a shield for the developing fetus inside the womb, protecting it from the constant ...
NOV 09, 2020
Microbiology
Fighting COVID-19 with Help From Llamas
NOV 09, 2020
Fighting COVID-19 with Help From Llamas
Camelids, which include llamas, alpacas and camels have immune systems that generate two kinds of antibodies when confro ...
Loading Comments...